REVELATION BIOSCIENCES, INC.

REVBW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $11.5M $14.1M $10.7M $12.7M $5.2M $3.7M $6.5M $6.5M
Accounts Receivable
Inventory
Total Current Assets $11.7M $14.2M $10.8M $12.8M $5.4M $3.9M $6.6M $6.7M
Property, Plant & Equipment $172.0K $140.7K $18.1K $23.9K $35.2K $42.4K $56.3K $81.2K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $12.5M $15.0M $11.6M $12.9M $5.4M $4.0M $6.6M $6.7M
Liabilities
Accounts Payable $931.1K $828.2K $577.5K $1.0M $828.9K $625.1K $783.6K $3.1M
Total Current Liabilities $1.9M $1.4M $2.0M $1.9M $1.6M $1.1M $1.9M $4.1M
Long-Term Debt
Total Liabilities $2.4M $2.1M $2.7M $1.9M $1.6M $1.1M $1.9M $4.1M
Stockholders' Equity
Retained Earnings $-55.8M $-52.4M $-49.4M $-46.9M $-45.0M $-42.6M $-40.5M $-38.8M
Total Stockholders' Equity $10.1M $13.0M $8.9M $11.0M $3.8M $2.9M $4.7M $2.7M
← Newer Page 1 of 4 Older →